siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma

類似資料

• siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
  著者:: de Martimprey, Henri, 等
  出版事項: (2008)
• Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations
  著者:: Ali, Hafiz Muhammad, 等
  出版事項: (2014)
• Potent Mitogenicity of the RET/PTC3 Oncogene Correlates with Its Prevalence in Tall-Cell Variant of Papillary Thyroid Carcinoma
  著者:: Basolo, Fulvio, 等
  出版事項: (2002)
• Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma : A Search for the Early Precursors of Papillary Cancer
  著者:: Fusco, Alfredo, 等
  出版事項: (2002)
• Papillary Thyroid Carcinoma Oncogene (RET/PTC) Alters the Nuclear Envelope and Chromatin Structure
  著者:: Fischer, Andrew H., 等
  出版事項: (1998)